Deltex Medical Group PLC represents a commitment to delivering high-quality patient monitoring solutions. With a corporate philosophy focused on enhancing patient outcomes, Deltex Medical aims to provide innovative technologies that improve clinical decision-making. The company's values include a dedication to improving patient safety, optimizing healthcare efficiency, and promoting evidence-based medicine. With a strong emphasis on research and development, Deltex Medical strives to continually push the boundaries of medical advancements in monitoring hemodynamic stability. By integrating cutting-edge technology with a patient-centric approach, Deltex Medical Group PLC is revolutionizing the field of healthcare monitoring.

Deltex Medical Group PLC primarily operates in the United Kingdom, Germany, France, Italy, Spain, the United States, and other countries worldwide.

Deltex Medical Group PLC has achieved several significant milestones. The company successfully developed and introduced the CardioQ-EDM+ system, a real-time hemodynamic monitoring platform. Deltex Medical Group PLC also launched a comprehensive hemodynamic therapy training program to educate healthcare professionals. Additionally, the company has established successful partnerships with numerous hospitals and healthcare providers globally, further expanding its reach and market presence. Deltex Medical Group PLC's commitment to innovation and collaboration has led to improved patient outcomes and recognition within the medical industry. Consequently, the company has gained a strong reputation as a leader in hemodynamic monitoring and therapy solutions.

Deltex Medical Group PLC is a renowned company specializing in advanced monitoring technologies for fluid management in surgery. Established in 1987, Deltex Medical Group PLC has emerged as a leader in providing innovative solutions to healthcare professionals. With a strong focus on research and development, the company has continuously evolved its proprietary esophageal Doppler monitoring technology, TrueVue, to optimize patient outcomes in various medical procedures. Deltex Medical Group PLC's cutting-edge products are trusted by medical communities worldwide, making it a globally recognized leader in hemodynamic monitoring. Continuously striving for excellence, Deltex Medical Group PLC remains committed to revolutionizing fluid management practices and improving patient care across the healthcare industry.

The main competitors of Deltex Medical Group PLC in the market include medical technology companies such as ICU Medical, Edwards Lifesciences Corporation, and Masimo Corporation. These companies offer similar types of monitoring and diagnostic technologies for healthcare professionals. However, Deltex Medical Group PLC differentiates itself through its innovative and non-invasive oesophageal Doppler monitoring system, which provides real-time hemodynamic data to optimize patient outcomes. With its advanced technology and focus on patient care, Deltex Medical Group PLC remains a key player in the market, offering unique and beneficial solutions for healthcare providers.

Deltex Medical Group PLC primarily operates in the healthcare industry.

The business model of Deltex Medical Group PLC is focused on the development and commercialization of innovative monitoring technologies for use in healthcare settings. Deltex Medical specializes in providing advanced hemodynamic monitoring solutions that help to optimize patient outcomes and reduce healthcare costs. By offering real-time, accurate, and minimally invasive monitoring systems, the company aims to enhance patient safety and improve clinical decision-making in surgical and critical care environments. Deltex Medical's business model revolves around delivering high-quality medical devices, supporting healthcare professionals in delivering superior patient care, and continually innovating to meet evolving market needs.

KGV за Deltex Medical Group в момента не може да бъде изчислено.

KUV за Deltex Medical Group в момента не може да бъде изчислено.

AlleAktien качественият резултат за Deltex Medical Group е 3/10.

Приходите не могат да бъдат изчислени в момента за Deltex Medical Group.

Печалбата за Deltex Medical Group в момента не може да бъде изчислена.

Deltex Medical Group PLC is a British company specializing in the development and distribution of innovative medical devices and technologies. With over 30 years of industry experience, the company is a leading provider of blood monitoring systems in Europe and the USA. The company operates in two main business areas: the sale of disposable products and the provision of services for the implementation of monitoring systems in hospitals and clinics. One of the company's important products is the CardioQ-ODM system, an advanced technology for monitoring heart and cardiovascular parameters during surgery. The system uses a patented sensor probe inserted into the patient's esophagus to provide real-time data on blood flow rate, volume, and other key indicators. This data enables surgeons to make real-time decisions and evaluate the effectiveness of measures to reduce complications such as organ failure. Another important product from Deltex is the TrueVue system, used in intensive care medicine. The system is able to monitor a patient's fluid status in real-time, preventing life-threatening complications. Deltex is also a leading company in this field. In addition, the company offers a range of disposable products such as catheters, sensor probes, monitoring systems, and accessories for use in hospitals and clinics. These products are marketed under the CardioQ-ODM and TrueVue brands and have gained popularity worldwide. Deltex Medical has experienced stable business growth in recent years and is constantly expanding into new markets. The company operates in the UK and the USA, with distribution partners in Europe, Asia, Australia, and New Zealand. A significant part of Deltex's business model is the provision of services. The company supports hospitals in the implementation of monitoring systems and provides comprehensive training programs for medical professionals. Although the company has historically been purchased mainly by wholesalers and pharmacies, it has gained importance for hospitals and medical professionals, especially during the Covid-19 pandemic. In summary, Deltex Medical Group PLC offers a unique combination of innovative products and comprehensive services for the medical field. The company is well-positioned to continue growing and strengthening its market position, contributing to improved healthcare.

Deltex Medical Group разпределя дивидента от 0 GBP на плащания годишно.

Дивидентата за Deltex Medical Group в момента не може да бъде изчислена или компанията не разпределя дивиденти.

ISIN на Deltex Medical Group е GB0059337583.

WKN на Deltex Medical Group е 927020.

Тикерът на Deltex Medical Group е DEMG.L.

През последните 12 месеца Deltex Medical Group изплати дивиденда в размер на . Това съответства на дивидендна доходност от около . За следващите 12 месеца се очаква Deltex Medical Group да изплати дивиденда в размер на 0 GBP.

Дивидентната доходност на Deltex Medical Group в момента е .

Deltex Medical Group изплаща дивидент на тримесечие. Той се разпределя в месеците .

Deltex Medical Group платеше дивиденда всяка година през последните 0 години.

За идните 12 месеца се очакват дивиденти в размер на 0 GBP. Това съответства на дивидентна доходност от 0 %.

Deltex Medical Group се отнася за сектор 'Здраве'.

За да получите последното дивидентно плащане от Deltex Medical Group на 11.11.2024 г. в размер на 0 GBP, трябваше да притежавате акцията в портфейла си преди Ex-деня на 11.11.2024 г..

Последното дивидентно плащане беше извършено на 11.11.2024 г..

През година 2023 Deltex Medical Group изплати 0 GBP под формата на дивиденти.

Дивидентите от Deltex Medical Group се изплащат в GBP.